Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies
Clinical trial NCT00239239 · COMPLETED
Trial details
- NCT number
- NCT00239239
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2007-01-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.